First photoactive drug for pain treatments

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first photoactive drug, light-activated drug –the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife. The new...

0

New therapeutic target that could slow Parkinson’s progression

A team of researchers of the Institute of Neurosciences of the University of Barcelona and the Institute for Bioengineering of Catalonia (IBEC) have identified a possible mechanism to slow the neurodegenerative progression of Parkinson’s disease. Parkinson’s neuronal degeneration is caused by Lewy bodies, abnormal aggregates created...

0